Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function

Urd Kielgast, Thure Krarup, Jens Juul Holst, Sten Madsbad, Thure Krarup

138 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function'. Together they form a unique fingerprint.

Medicine & Life Sciences